Updates on HIV Pre-exposure Prophylaxis in Latin America: Available Drugs and Implementation Status
Latin America has reported a 9% increase in new HIV infections from 2010 to 2023. Pre-exposure prophylaxis (PrEP) is a crucial biomedical intervention for preventing HIV transmission. Currently, several antiretroviral drugs, in various forms of administration, have demonstrated high efficacy and eff...
Guardado en:
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | inglés |
| Publicado: |
2025
|
| Materias: | |
| Acceso en línea: | Ver en el sistema de origen Enlace permanente (DOI o Handle) Enlace permanente (DOI o Handle) |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Updates on HIV Pre-exposure Prophylaxis in Latin America: Available Drugs and Implementation Status
- Implementing the SDGs in Higher Education: A Systematic Review
- The moderating effect of resilience on the relationship between exposure to domestic violence and academic dishonesty in Peruvian adolescents
- Air Pollution and Pediatric Central Nervous Tumors: A Systematic Review of Evidence and Public Health Implications
- Associations of ambient exposure to benzene, toluene, ethylbenzene, and xylene with daily mortality: a multicountry time-series study in 757 global locations
- Implementing point-of-care medical information systems into trauma and general surgeon practice in a middle-income country: a qualitative study utilizing the Consolidated Framework for Implementation Research
- IFN-γ Response Is Associated to Time Exposure Among Asymptomatic Immune Responders That Visited American Tegumentary Leishmaniasis Endemic Areas in Peru